Cartimage is a Medical Device company founded in 2014 as a spinoff of the University of Grenoble-Alps, in France. Our goal is to develop per-operative imaging devices to help surgeons preserve original tissues in order to prevent long-term adverse effects.
Our first objective is to Save the Meniscus. Our device, ChondroSight, will be a guidance for knee arthroscopic procedures, showing which meniscal lesions can be repaired with a high probability of success.
Currently, only 20% of meniscal lesions are repaired ; 30% are left in place and 50% lead to meniscectomies. Our goal is to reach as high as 60% of repair.
Beyond the knee meniscus, our device also has applications in lung surgery, shoulder tendinoplasty, and cartilage repair.
|Cartimage was awarded grant prizes in 2015 (French Ministry of Research’s ILAB competition) and 2016 (Bpifrance’s Concours Mondial d’Innovation) and is now open to private equity investment.||
Cartimage Medical SAS
5, avenue du Grand Sablon
F-38700 La Tronche